March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...
March 23, 2026 Critical Path Institute and Collaborators Honored with Society of Toxicology Science Paper of the Year Award TUCSON, Ariz., March 23, 2026 — Critical Path Institute® (C-Path) announced today that the Society of Toxicology (SOT)...
March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
March 3, 2026 Critical Path Institute’s Translational Therapeutics Accelerator Awards Grant to Support Development of Novel Nonopioid Pain Therapeutics TUCSON, Ariz., March 3, 2026 — Critical Path Institute’s® (C-Path) Bridging Research and Innovation in Drug Development...
February 25, 2026 C-Path Appoints Renowned Harvard Health Economist Amitabh Chandra to Board of Directors C-Path today announced the appointment of Amitabh Chandra, Ph.D., to its Board of Directors. Professor Chandra ...
January 28, 2026 C-Path’s New Clinical Pharmacology & Therapeutics Publication Highlights Real-World Impact of FDA-Qualified Urine Biomarkers for Earlier Detection of Drug-Induced Kidney Injury C-Path) Predictive Safety Testing Consortium today announced the publication of a new peer-reviewed...
January 21, 2026 C-Path’s Translational Therapeutics Accelerator Announces 2026 Request for Proposals from Academic Investigators TUCSON, Ariz., January 21, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator today...
November 24, 2025 C-Path Consortium Adds Gene Editing and Advanced Imaging Leaders to Accelerate Alpha-1 Research Beam Therapeutics and the Open Source Imaging Consortium join C-Path’s CPA-1 program, bringing gene editing innovation and...
November 20, 2025 C-Path Announces New Name and Strategic Direction for its PRO Consortium C-Path's PRO Consortium has adopted a new name, the Patient-Centered Evidence Consortium (PCEC), to reflect its...